HFE genotype affects exosome phenotype in cancer

• Published in: Biochimica et biophysica acta. General subjects Vol. 1861; no. 8; pp. 1921 - 1928
• Main Authors: Mrowczynski, Oliver D., Madhankumar, A.B., Slagle-Webb, Becky, Lee, Sang Y., Zacharia, Brad E., Connor, James R.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2017
• Subjects: Angiogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular proliferation; childhood; Exosomes; Exosomes - metabolism; functional properties; genes; genetic polymorphism; Genotype; hemochromatosis; Hemochromatosis Protein - genetics; HFE; Humans; Invasion; metastasis; Migration; monitoring; mutants; Mutation; Neoplasm Invasiveness; neoplasms; Neuroblastoma; Neuroblastoma - genetics; Neuroblastoma - pathology; patients; Phenotype; proteins; Therapeutic resistance; therapeutics; Whites; Angiogenesis; Cellular proliferation; HFE; Migration; Genotype; Neuroblastoma; Exosomes; Therapeutic resistance; Invasion
• ISSN: 0304-4165; 1872-8006
• DOI: 10.1016/j.bbagen.2017.05.014

Neuroblastoma is the third most common childhood cancer, and timely diagnosis and sensitive therapeutic monitoring remain major challenges. Tumor progression and recurrence is common with little understanding of mechanisms. A major recent focus in cancer biology is the impact of exosomes on metastatic behavior and the tumor microenvironment. Exosomes have been demonstrated to contribute to the oncogenic effect on the surrounding tumor environment and also mediate resistance to therapy. The effect of genotype on exosomal phenotype has not yet been explored. We interrogated exosomes from human neuroblastoma cells that express wild-type or mutant forms of the HFE gene. HFE, one of the most common autosomal recessive polymorphisms in the Caucasian population, originally associated with hemochromatosis, has also been associated with increased tumor burden, therapeutic resistance boost, and negative impact on patient survival. Herein, we demonstrate that changes in genotype cause major differences in the molecular and functional properties of exosomes; specifically, HFE mutant derived exosomes have increased expression of proteins relating to invasion, angiogenesis, and cancer therapeutic resistance. HFE mutant derived exosomes were also shown to transfer this cargo to recipient cells and cause an increased oncogenic functionality in those recipient cells. •Genotype can influence exosome impact on recipient cells.•Exosomes from HFE mutant cells transfer tumorigenic properties to recipient cells.•HFE genotype can significantly impact cancer outcomes.